May 6-8, 2019 at the Sheraton Centre Hotel, Toronto. This three day Annual General Meeting and Convention is a must-attend annual event for professionals who work in senior care. To learn more or to register click here.
April 10, 2019 from 12-1 PM EST. Join presenter Patrick Rooney, PhD Candidate as he discusses the fundamentals of behavioural research; insights from behavioural science to help shape workplaces, processes and interactions and specific examples aimed at nudging better outcomes in healthcare. Register here.
May 16, 2019 from 1:30-2:30 PM EST. Join presenters, Peter Tanuseputro, MD and Julie Lapenskie, MScAH as they focus on ethnic, linguistic, Two Spirit LGBTQ+, and immigrant minority populations in Ontairo LTC homes. To learn more or to register click here.
This UK report aims to raise awareness of an often overlooked population, to promote greater understanding of support needs and recommend approaches that offer better, high quality care. 16 pages. Last reviewed March 2019.
This billingual article describes the findings of a cross-sectional, self-administered survey of Canadian family physicians and other health professionals investigating perceived barriers and enablers of advance care planning (ACP) in the primary care setting. 9 pages. Last reviewed March 2019.
This study underscores the need to consider gender identify and sexual orientation at end-of-life. In particular, recognition of intersectionality and social locations is crucial to facilitating positive aging experiences and end-of-life care. 10 pages. Last reviewed March 2019.
This publication summarizes the literature on the evidence of using endocannabinoid system medications and their ability to modulate neuroinflammation and oxidative stress in Alzheimer’s Disease. 15 pages. Last reviewed March 2019.
The authors described the findings of a cross-sectional study which provided empirical evidence that prolonged use of inhaled or ingested street cannabis in patients with MS is associated with poorer performance on cognitive domains commonly affected in this population. 8 pages. Last reviewed March 2019.
This publication describes the findings of a review of medical marijuana (1948-2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy and movement disorders. 8 pages. Last reviewed March 2019.